Fig. 5.
IRS-1 phosphorylation sites not significantly affected by type 2 diabetes in muscle in vivo. Experiments were performed identically with those described in Fig. 1. T2D, type 2 diabetes
IRS-1 phosphorylation sites not significantly affected by type 2 diabetes in muscle in vivo. Experiments were performed identically with those described in Fig. 1. T2D, type 2 diabetes